Results 1 to 10 of about 4,144,108 (357)

Position Statement on COVID-19 Infection and Diabetes

open access: yesJournal of the ASEAN Federation of Endocrine Societies, 2020
Coronavirus disease 2019 (COVID-19) has affected millions of lives worldwide, posing unprecedented challenges to global public health. It has infected people of different backgrounds, and from all industries, including healthcare workers.
The Philippine Society of Endocrinology, Diabetes and Metabolism (PSEDM)
doaj   +1 more source

Identification of Two Novel Mutations of ABCD1 Gene in Pedigrees with X-Linked Adrenoleukodystrophy and Review of the Literature

open access: yesInternational Journal of Endocrinology, 2022
Background. X-linked adrenoleukodystrophy (ALD) is an inherited peroxisomal metabolism disorder, resulting from the loss-of-function mutation of ATP-binding cassette protein subfamily D1 (ABCD1) gene.
Bingzi Dong   +8 more
doaj   +1 more source

Differences of Circulating CD25hi Bregs and Their Correlations with CD4 Effector and Regulatory T Cells in Autoantibody-Positive T1D Compared with Age-Matched Healthy Individuals

open access: yesJournal of Immunology Research, 2022
Circulating CD25hi B cells, a subset of regulatory B cells in humans, are closely related to inflammation and autoimmune diseases. This study is aimed at investigating the alternation of CD25hi Bregs and their correlation with CD4 effector and regulatory
Jie Zhang   +9 more
doaj   +1 more source

Low Serum Total Testosterone Is Associated with Non-Alcoholic Fatty Liver Disease in Men but Not in Women with Type 2 Diabetes Mellitus

open access: yesInternational Journal of Endocrinology, 2022
Aims/Introduction. Sex steroid hormones play a significant role in the progression of cardiovascular and metabolic diseases, including non-alcoholic fatty liver disease (NAFLD).
Xinxin Zhang   +8 more
doaj   +1 more source

Caveolin-1 Is Essential for the Improvement of Insulin Sensitivity through AKT Activation during Glargine Treatment on Diabetic Mice

open access: yesJournal of Diabetes Research, 2021
Insulin treatment was confirmed to reduce insulin resistance, but the underlying mechanism remains unknown. Caveolin-1 (Cav-1) is a functional protein of the membrane lipid rafts, known as caveolae, and is widely expressed in mammalian adipose tissue ...
Hangya Peng   +8 more
doaj   +1 more source

Combination of GLP-1 Receptor Activation and Glucagon Blockage Promotes Pancreatic β-Cell Regeneration In Situ in Type 1 Diabetic Mice

open access: yesJournal of Diabetes Research, 2021
Pancreatic β-cell neogenesis in vivo holds great promise for cell replacement therapy in diabetic patients, and discovering the relevant clinical therapeutic strategies would push it forward to clinical application.
Liangbiao Gu   +7 more
doaj   +1 more source

Intermediary metabolism [PDF]

open access: yes, 2009
Caenorhabditis elegans has orthologs for most of the key enzymes involved in eukaryotic intermediary metabolism, suggesting that the major metabolic pathways are probably present in this species.
Braeckman, Bart   +2 more
core   +2 more sources

Chapter 11: The approach to achieving glycaemic control

open access: yesSouth African Family Practice, 2018
Type 2 diabetes is a heterogeneous disease, with the underlying mechanism ranging from predominantly insulin resistance with relative insulin deficiency, to predominantly an insulin secretory defect with lesser degrees of insulin resistance. The relative
The The Society for Endocrinology, Metabolism and Diabetes of South Africa
doaj   +1 more source

The Relationships among Plasma Fetuin-B, Thyroid Autoimmunity, and Fertilization Rate In Vitro Fertilization and Embryo Transfer

open access: yesInternational Journal of Endocrinology, 2022
Objective. The objective of the study is to investigate the relationships between fetuin-B, thyroid autoimmunity (TAI), and pregnancy outcomes in women undergoing in vitro fertilization and embryo transfer (IVF-ET). Design, Patients, and Measurements. In
Rui Zhang   +7 more
doaj   +1 more source

Glucose Control: non-insulin therapies*

open access: yesSouth African Family Practice, 2018
This chapter summarises information for each of the non-insulin drug classes that are used for blood glucose control. Each summary is accompanied by a table of recommendations to guide the clinical use of these medications.
The Society for Endocrinology, Metabolism and Diabetes of South Africa
doaj   +1 more source

Home - About - Disclaimer - Privacy